Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Johnson & Johnson has acquired Atraverse Medical, a medical devices business in the United States. Atraverse Medical develops and commercializes healthcare medical device technologies, supporting clinical workflows and patient care. Johnson & Johnson acquisitions in medical devices acquisition categories often focus on expanding product capabilities and strengthening strategic acquisition pipelines in key markets. This other acquisition is announced and structured as a strategic acquisition by a corporate buyer, with deal size undisclosed and terms not publicly specified.
Source
Read full article on todaysmedicaldevelopments.comvia GN - entered into definitive agreement · April 27, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026